+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pediatric Cardiac Tumor Diagnostic Market Size, Share & Trend Analysis Report By Tumor (Primary Cardiac Tumors, Secondary Cardiac Tumors), By Type (Echocardiography, MRI), By End-use, By Region, and Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 160 Pages
  • August 2024
  • Region: Global
  • Grand View Research
  • ID: 5998914
Description Jump to:

Pediatric Cardiac Tumor Diagnostic Market Growth & Trends

The global pediatric cardiac tumor diagnostic market size is anticipated to reach USD 1.06 billion by 2030 and is projected to grow at a CAGR of 8.03% from 2024 to 2030. The growth of the market is attributed to the increasing awareness and advancements in medical technology. With the rise in the prevalence of congenital heart conditions and tumors among children, the demand for accurate and early diagnostic tools has surged. Technological innovations, such as advanced imaging techniques and improved biomarkers, have enhanced diagnostic capabilities, allowing for earlier detection and better management of pediatric cardiac tumors. For instance, in June 2021, the Spanish National Center for Cardiovascular Research and Philips teamed up to develop an ultra-fast cardiac MRI protocol for research purposes. This collaboration aims to enhance clinical practice in the future, including advancements in oncology research. These innovations improve patient outcomes and drive market growth as healthcare providers seek more effective solutions for diagnosing and treating these rare conditions.

Moreover, technological advancements significantly impact the market for pediatric cardiac tumor diagnostics, driving its growth. The development of high-resolution MRI and CT scan technologies allows for more accurate and detailed imaging of cardiac tumors in children. These imaging modalities enhance early detection and precise diagnosis, which are crucial for effective treatment. In addition, the integration of artificial intelligence (AI) into diagnostic processes is further improving accuracy and efficiency by analyzing complex imaging data.As these technologies evolve, they are expected to expand market growth by providing better diagnostic tools, improving patient outcomes, and reducing healthcare costs associated with pediatric cardiac tumor care.

The investment in pediatric care and funding for oncology research are pivotal factors driving the growth of the market. Increased investment in pediatric healthcare ensures the development of advanced diagnostic tools and technologies, such as high-resolution MRI and CT scans, which are crucial for accurately detecting and monitoring cardiac tumors in children. For instance,in June 2024, Amazon Web Services Inc. invested USD 10 million to advance research in pediatric healthcare and enhance the understanding of rare diseases, including tumors. These investments not only accelerate technological advancements but also expand the market by improving the quality of care and increasing the availability of innovative diagnostic solutions.

Furthermore, increased public and professional understanding of pediatric oncology care drives demand for advanced diagnostic tools and early detection methods. For instance, International Childhood Cancer Day is a worldwide initiative aimed at raising awareness about childhood cancer and showing support for affected children, adolescents, survivors, and their families. As awareness grows, so does the market for specialized imaging technologies and treatments, leading to more investment and innovation in this field. This heightened focus on pediatric care supports market expansion and improves outcomes for children with cardiac tumors.

Pediatric Cardiac Tumor Diagnostic Market Report Highlights

  • The primary cardiac tumors segment held the largest share, 84.81%, in 2023due to advancements in imaging technologies, increased awareness, and improved diagnostic tools. These factors enhance early detection and treatment, driving market expansion.
  • The echocardiography segment held the largest share, 60.76%, in 2023 due to its noninvasive nature, advanced imaging capabilities, and enhanced diagnostic accuracy. Key players like Philips and GE Healthcare drive innovation with advanced technology, improving early detection and treatment outcomes.
  • The hospitals and clinics segment held the largest share, 73.89%, in 2023, fueledby improved healthcare infrastructure, increased funding, and investment. Enhanced facilities and resources support advanced diagnostic technologies, leading to better detection and management of pediatric cardiac tumors.
  • The North America region dominated the overall global market for pediatric cardiac tumor diagnosticsand accounted for the 36.44% revenue share in 2023. Strategic development and innovation, including advanced imaging technologies and research, drive market growth and enhance diagnostic accuracy in this region.
  • The competitive scenario in the pediatric cardiac tumor diagnostic market is high, with key players holding significant positions. The major companies are undertaking various strategies, such as new product development, acquisitions, collaborations, mergers, and regional expansion, to serve their customers' unmet needs.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Tumor
1.2.2. Type
1.2.3. End use
1.2.4. Regional Scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Tumor outlook
2.2.2. Type outlook
2.2.3. End use outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Pediatric Cardiac Tumor Diagnostic Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Pediatric Cardiac Tumor Diagnostic Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Pediatric Cardiac Tumor Diagnostic Market: Tumor Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Pediatric Cardiac Tumor Diagnostic Market: Tumor Movement Analysis
4.3. Pediatric Cardiac Tumor Diagnostic Market by Tumor Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Primary Cardiac Tumors
4.5.1. Primary Cardiac Tumors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Secondary Cardiac Tumors
4.5.2.1. Secondary Cardiac Tumors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Pediatric Cardiac Tumor Diagnostic Market: Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Pediatric Cardiac Tumor Diagnostic Market: Type Movement Analysis
5.3. Pediatric Cardiac Tumor Diagnostic Market by Type Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Echocardiography
5.5.1. Echocardiography Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Magnetic Resonance Imaging (MRI)
5.6.1. Magnetic Resonance Imaging (MRI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Computed Tomography (CT) Scan
5.7.1. Computed Tomography (CT) Scan Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Others
5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Pediatric Cardiac Tumor Diagnostic Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Pediatric Cardiac Tumor Diagnostic Market: End Use Movement Analysis
6.3. Pediatric Cardiac Tumor Diagnostic Market by End Use Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Hospitals and Clinics
6.5.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Government Health Department
6.6.1. Government Health Department Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Pediatric Cardiac Tumor Diagnostic Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. GE HealthCare
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Siemens Healthineers AG
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. CANON MEDICAL SYSTEMS CORPORATION
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Boston Scientific Corporation
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Lantheus
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Bio-Rad Laboratories, Inc.
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Abbott
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. F. Hoffmann-La Roche Ltd
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Medtronic
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 4. Global pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 5. Global pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 6. North America pediatric cardiac tumor diagnostic market, by region, 2018 - 2030 (USD Million)
Table 7. North America pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 8. North America pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 9. North America pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 10. U.S. pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 11. U.S. pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 12. U.S. pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 13. Canada pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 14. Canada pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 15. Canada pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 16. Mexico pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 17. Mexico pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 18. Mexico pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 19. Europe pediatric cardiac tumor diagnostic market, by country, 2018 - 2030 (USD Million)
Table 20. Europe pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 21. Europe pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 22. Europe pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 23. UK pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 24. UK pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 25. UK pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 26. Germany pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 27. Germany pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 28. Germany pediatric cardiac tumor diagnostic market, by end use 2018 - 2030 (USD Million)
Table 29. France pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 30. France pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 31. France pediatric cardiac tumor diagnostic market, by end use 2018 - 2030 (USD Million)
Table 32. Italy pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 33. Italy pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 34. Italy pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 35. Spain pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 36. Spain pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 37. Spain pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 38. Denmark pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 39. Denmark pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 40. Denmark pediatric cardiac tumor diagnostic market, by end use 2018 - 2030 (USD Million)
Table 41. Norway pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 42. Norway pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 43. Norway pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 44. Sweden pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 45. Sweden pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 46. Sweden pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 47. Asia Pacific pediatric cardiac tumor diagnostic market, by country, 2018 - 2030 (USD Million)
Table 48. Asia Pacific pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 49. Asia Pacific pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 50. Asia Pacific pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 51. Japan pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 52. Japan pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 53. Japan pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 54. China pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 55. China pediatric cardiac tumor diagnostic market, by type 2018 - 2030 (USD Million)
Table 56. China pediatric cardiac tumor diagnostic market, by end use 2018 - 2030 (USD Million)
Table 57. India pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 58. India pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 59. India pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 60. Australia pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 61. Australia pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 62. Australia pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 63. South Korea pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 64. South Korea pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 65. South Korea pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 66. Thailand pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 67. Thailand pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 68. Thailand pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 69. Latin America pediatric cardiac tumor diagnostic market, by country, 2018 - 2030 (USD Million)
Table 70. Latin America pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 71. Latin America pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 72. Latin America pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 73. Brazil pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 74. Brazil pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 75. Brazil pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 76. Argentina pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 77. Argentina pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 78. Argentina pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 79. Middle East & Africa pediatric cardiac tumor diagnostic market, by country, 2018 - 2030 (USD Million)
Table 80. Middle East & Africa pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 81. Middle East & Africa pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 82. Middle East & Africa pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 83. South Africa pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 84. South Africa pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 85. South Africa pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 86. Saudi Arabia pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 87. Saudi Arabia pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 88. Saudi Arabia pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 89. UAE pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 90. UAE pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 91. UAE pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
Table 92. Kuwait pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
Table 93. Kuwait pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
Table 94. Kuwait pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Information procurement
Fig. 2 Primary research pattern
Fig. 3 Market research approaches
Fig. 4 Value chain-based sizing & forecasting
Fig. 5 Market formulation & validation
Fig. 6 Pediatric cardiac tumor diagnostic market segmentation
Fig. 7 Market driver analysis (current & future impact)
Fig. 8 Market restraint analysis (current & future impact)
Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 10 Porter’s five forces analysis
Fig. 11 Pediatric cardiac tumor diagnostic market, tumor outlook key takeaways (USD Million)
Fig. 12 Pediatric cardiac tumor diagnostic market: tumor movement analysis (USD Million), 2023 & 2030
Fig. 13 Primary cardiac tumors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 14 Secondary cardiac tumors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 15 Pediatric cardiac tumor diagnostic market, type outlook key takeaways (USD Million)
Fig. 16 Pediatric cardiac tumor diagnostic market: type movement analysis (USD Million), 2023 & 2030
Fig. 17 Echocardiography market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Magnetic Resonance Imaging (MRI) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Computed Tomography (CT) scan market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Pediatric cardiac tumor diagnostic market, end use outlook key takeaways (USD Million)
Fig. 22 Pediatric cardiac tumor diagnostic market: end use movement analysis (USD Million), 2023 & 2030
Fig. 23 Hospitals and clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Government health department market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Pediatric cardiac tumor diagnostic market: regional key takeaways (USD Million)
Fig. 27 Pediatric cardiac tumor diagnostic market: regional outlook, 2023 & 2030, USD Million
Fig. 28 North America pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 U.S. pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Canada pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Mexico pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Europe pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 UK pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Germany pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 France pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Spain pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Italy pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Norway pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Denmark pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Sweden pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Asia Pacific pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 China pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Japan pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 India pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 South Korea pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Australia pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Thailand pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Latin America pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Brazil pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Argentina pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Middle East and Africa pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 South Africa pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Saudi Arabia pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 UAE pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Kuwait pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 List of key emerging company’s/type disruptors/innovators

Companies Mentioned

  • GE HealthCare
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • CANON MEDICAL SYSTEMS CORPORATION
  • Boston Scientific Corporation
  • Lantheus
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • Medtronic

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages160
PublishedAugust 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 632.34 Million
Forecasted Market Value ( USD ) by 2030 $ 1060 Million
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Pediatric Cardiac Tumor Diagnostic Market by Tumor, by Type, by End-User, and By Region - Product Image

Global Pediatric Cardiac Tumor Diagnostic Market by Tumor, by Type, by End-User, and By Region

  • Report
  • 200 Pages
  • Global
From
Pediatric Cancer Biomarkers Market Size, Share and Trends Analysis Report by Indication (Leukemia, Neuroblastoma, CNS Tumors, Lymphoma), Biomarker (Alpha-Fetoprotein, Neuron-Specific Enolase), End-use 2024-2030 - Product Image

Pediatric Cancer Biomarkers Market Size, Share and Trends Analysis Report by Indication (Leukemia, Neuroblastoma, CNS Tumors, Lymphoma), Biomarker (Alpha-Fetoprotein, Neuron-Specific Enolase), End-use 2024-2030

  • Report
  • 120 Pages
  • Global
From
Pediatric Allergy Diagnostics Market Size, Share and Trends Analysis Report by Product (Instruments, Consumables), Allergen (Food, Inhaled, Drug), Test (in Vivo Test, in Vitro Test), and Region 2024-2030 - Product Image

Pediatric Allergy Diagnostics Market Size, Share and Trends Analysis Report by Product (Instruments, Consumables), Allergen (Food, Inhaled, Drug), Test (in Vivo Test, in Vitro Test), and Region 2024-2030

  • Report
  • 120 Pages
  • Global
From
Caffey's Pediatric Diagnostic Imaging, 2-Volume Set. Edition No. 13 - Product Image

Caffey's Pediatric Diagnostic Imaging, 2-Volume Set. Edition No. 13

  • Book
Nadas' Pediatric Cardiology. Edition No. 3 - Product Image

Nadas' Pediatric Cardiology. Edition No. 3

  • Book
Copyright © 2002-2024 Research and Markets. All Rights Reserved.